Erythropoietin combined with radiation therapy does not improve local-regional control in anemic patients with head and neck cancer

(American Society for Radiation Oncology) Long-term analysis of Radiation Therapy Oncology Group 9903 demonstrates that the addition of erythropoietin did not improve local-regional control for anemic patients with head and neck squamous cell carcinoma who receive radiation therapy or chemoradiation, according to a study published in the April 1, 2015 issue of the International Journal of Radiation Oncology * Biology * Physics.